chartexchange

NMRD
NEMAURA MEDICAL INC
stockOTC

EODNov 16, 2026
0.0001USD0.000%(0.00)790
Loading…
Loading…
Healthcare
Medical Devices
CEO
Dewan Chowdhury
HQ
New York, NY, USA
Previous Close
$0.00
Beta
-209.42
52-Week High
$0.00 2026-11-09
52-Week Low
$0.00 2026-11-02
SMA 50
$0.00
SMA 200
$0.01
Avg. Vol 10D
2,486
Avg. Vol 30D
3,970
Avg. Vol 90D
5,434
Relative Vol
0.20
17.26M
Dec 5, 2019 · 1-for-10 (reverse)
NMRD Profile

nemaura medical inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. the company provides sugarbeat, a non-invasive continuous glucose monitoring device for use by persons with type i and type ii diabetes, as well as for screening pre-diabetic patients. it has a license agreement with healthimation, llc, which licenses the company to make, have made, use, offer to sell, sell, and import intensive medical diabetes and weight management program for type 2 diabetes, prediabetes, and general wellness; the why wait app; and common law trademarks which incorporate the mark why wait or whywait and the use of licensed marks. nemaura medical inc. was founded in 2009 and is based in new york, new york.

NMRD Performance
PeriodPriceDateChangeBeta
1Y0.002025-11-17-50.00%-209.424
2Y0.002024-11-14+9900.00%—
5Y4.912021-11-19-100.00%-10.445
NMRD Stock Summary

NEMAURA MEDICAL INC (OTC:NMRD) stock price today is $0.00, and today's volume is 790. NMRD is up 0.000% today. The 30 day average volume is 3,970. NMRD market cap is $4,035 with 40.35M shares outstanding.